Financial Enhancement Group LLC Novartis Ag Transaction History

Financial Enhancement Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 18, 2022	BUY	$80.11 - $90.62 $3,604 - $4,077	45 New	45 $4,000
Q4 2020 Feb 10, 2021	SELL	$78.07 - $94.43 $2,888 - $3,493	-37 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$75.4 - $92.8 $15,834 - $19,488	-210 Reduced 85.02%	37 $3,000
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $18,604 - $21,279	247 New	247 $24,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $216B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

Stay updated on Financial Enhancement Group LLC with notifications on news.